Vasamed, Inc

Form 483 issued May 16, 2019 · Eden Prairie, Minnesota

Inspection
May 13 – May 16, 2019
Observations
2
Pages
6
FEI number
1000116119

In short: On May 16, 2019, FDA issued a Form 483 with 2 observations to Vasamed, Inc in Eden Prairie, Minnesota (FEI 1000116119) after an inspection that ran May 13 – May 16, 2019. The investigators were Jennifer S. Ness, Marissa S. Steinhagen and Tiffany P. Kelley. Most observations concern design controls and production & process controls; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

Design controls and production & process controls account for 2 of 2 observations.

Design controls1
Production & process controls1

Most cited: 21 CFR 820.30(i) (1×) · 820.80(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for design change have…

  2. 02

    Procedures for acceptance of incoming product…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Vasamed, Inc?

FDA listed 2 observations on this Form 483, mostly about design controls and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Vasamed, Inc?

Jennifer S. Ness, Marissa S. Steinhagen and Tiffany P. Kelley are named on this Form 483, for the inspection of May 13 – May 16, 2019. Each investigator has a profile showing what they cite most.

When was Vasamed, Inc inspected by FDA?

The inspection ran May 13 – May 16, 2019, and the Form 483 is dated May 16, 2019.

How do I get the full Form 483 for Vasamed, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free